Current trends in managing the anophthalmic socket after primary enucleation and evisceration

Ophthalmic Plastic and Reconstructive Surgery

Volumn 20, Issue 4, 2004, Pages 274-280

  Su, Grant W ^a   Yen, Michael T ^a  

^a CULLEN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYAPATITE; POLYETHYLENE; POLYGLACTIN;

ALLOGRAFT; ANOPHTHALMIA; DEVICE INFECTION; ENUCLEATION; EVISCERATION; EXPOSURE; HUMAN; ORBIT IMPLANT; ORBIT RECONSTRUCTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PYOGENIC GRANULOMA; REVIEW; SCLERA; SURGICAL TECHNIQUE;

ANOPHTHALMOS; COATED MATERIALS, BIOCOMPATIBLE; DURAPATITE; EYE ENUCLEATION; EYE EVISCERATION; HUMANS; INTRAOPERATIVE COMPLICATIONS; OPHTHALMOLOGIC SURGICAL PROCEDURES; OPHTHALMOLOGY; ORBIT; ORBITAL IMPLANTS; PHYSICIAN'S PRACTICE PATTERNS; POLYETHYLENE; POSTOPERATIVE COMPLICATIONS;

EID: 3242812181     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.IOP.0000129528.16938.1E     Document Type: Review

References (57)

1. Mules PH. Evisceration of the globe with artificial vitreous: 1884-1895. Adv Ophthal Plast Reconstr Surg 1990;8:69-72.
2. Jordan DR. Anophthalmic orbital implants. Ophthalmol Clin North Am 2000;13:587-608.
3. Allen JH, Allen L. A buried muscle cone implant. I. Development of a tunneled hemispherical type. Arch Ophthalmol 1950;43:879-90.
4. Spivey BE, Allen L, Burns CA. The Iowa enucleation implant: a ten year evaluation of techniques and results. Am J Ophthalmol 1969;67:171-81.
5. Jordan DR, Anderson RL, Nerad J, et al. A preliminary report on the universal implant. Arch Ophthalmol 1985;105:1726-31.
6. Homblass A, Biesman BS, Eviatar JA. Current techniques of enucleation: a survey of 5,439 intraorbital implants and a review of the literature. Ophthal Plast Reconstr Surg 1995;11:77-86.
7. Perry AC. Advances in enucleation. Ophthal Plast Reconstr Surg 1991;4:173-82.
8. Karesh JW, Dresner SC. High density porous polyethylene (Medpor) as a successful anophthalmic socket implant. Ophthalmology 1994;101:1688-96.
9. Rubin PA, Popham, J, Rumeldts S, et al. Enhancement of the cosmetic and functional outcomes of enucleation with the conical orbital implant. Ophthalmology 1998;105:919-25.
10. Jordan DR, Gilberg S, Mawn L, et al. The synthetic hydroxyapatite implant: a report of 65 patients. Ophthal Plast Reconstr Surg 1998;14:250-5.
11. Hintschich C, Raithel E, Craig GT, et al. Glass-ionomer cement: evaluation as an orbital implant. Graefes Arch Clin Exp Ophthalmol 1999;237:169-74.
12. Jordan DR, Pelletier C, Gilberg S, et al. The Chinese hydroxyapatite implant. Ophthal Plast Reconstr Surg 1999;15:420-4.
13. Jordan DR, Hwang I, McEachren T, et al. The Brazilian implant. Ophthal Plast Reconstr Surg 2000;16:636-9.
14. Jordan DR, Hwang I, Gilberg S, et al. The Molteno M-Sphere. Ophthal Plast Reconstr Surg 2000;16:356-62.
15. Jordan DR, Mawn L, Gilberg S, et al. The Bioceramic implant: a new generation of porous orbital implants. Ophthal Plast Reconstr Surg 2000;16:347-53.
16. Murray TG, Cicciarelli NL, Croft BH, et al. Design of a magnetically integrated microporous implant. Arch Ophthalmol 2000;118:1259-62.
17. Schellini SA, Xavier AP, Hoyama E, et al. Gelatinous polyethylene in the treatment of the anophthalmic cavity. Orbit 2002;21:189-93.
18. Perry JD, Goldberg RA, McCann JD, et al. Bovine hydroxyapatite orbital implant: a preliminary report. Ophthal Plast Reconstr Surg 2002;18:268-74.
19. Anderson RL, Yen MT, Lucci LM, et al. The Quasi-integrated porous polyethylene orbital implant. Ophthal Plast Reconstr Surg 2002;18:50-5.
20. Jordan DR Allen L, Ells A, et al. The use of Vicryl (polyglactin 910) for implantation of hydroxyapatite orbital implants. Ophthal Plast Reconstr Surg 1995;11:95-9.
21. Beaver HA, Patrinely JR, Holds JB, Soper MP. Periocular autografts in socket reconstruction. Ophthalmology 1996;103:1498-502.
22. Oestreicher JH, Liu E, Berkowitz M. Complications of hydroxyapatite orbital implants: a review of 100 consecutive cases and a comparison of Dexon mesh (polyglycolic acid) with scleral wrapping. Ophthalmology 1997;104:324-9.
23. Kao SC, Chen S. The use of rectus abdominis sheath for wrapping of the hydroxyapatite orbital implants. Ophthal Surg Lasers 1999;30:69-71.
24. Massry GG, Holds JB. Frontal periosteum as an exposed orbital implant cover. Ophthal Plast Reconstr Surg 1999;15:79-82.
25. Rubin PA, Fay AM, Remulla HD, Maus M. Ophthalmic plastic applications of acellular dermal allografts. Ophthalmology 1999;106:2091-7.
26. Naugle TC Jr, Lee AM, Haik BG, Callahan MA. Wrapping hydroxyapatite orbital implants with posterior auricular muscle complex grafts. Am J Ophthalmol 1999;128:495-501.
27. Kao LY. Polytetrafluoroethylene as a wrapping material for a hydroxyapatite orbital implant. Ophthal Plast Reconstr Surg 2000;16:286-8.
28. Klapper SR, Jordan, DR, Punja K, et al. Hydroxyapatite implant wrapping materials: analysis of fibrovascular ingrowth in an animal model. Ophthal Plast Reconstr Surg 2000;16:278-85.
29. Gayre GS, Debacker C, Lipham W, et al. Bovine pericardium as a wrapping for orbital implants. Ophthal Plast Reconstr Surg 2001;17:381-7.
30. Goldberg RA. Who should have hydroxyapatite orbital implants? Arch Ophthalmol 1995;113:566-7.
31. Codere F. Hydroxyapatite implants: a rational approach. Can J Ophthalmol 1995;30:235-7.
32. Beard C. Remarks on historical and newer approaches to orbital implants. Ophthal Plast Reconstr Surg 1995;11:89-90.
33. Cepela M, Teske S. Orbital implants. Curr Opin Ophthalmol 1996;7:38-42.
34. Custer PL. Enucleation: past, present, and future. Ophthal Plast Reconstr Surg 2000;16:316-21.
35. Moshfeghi DM, Moshfeghi AA, Finger PT. Enucleation. Surv Ophthalmol 2000;44:277-30.
36. Guillinta P, Vasani SN, Granet DB, Kikkawa DO. Prosthetic motility in pegged versus unpegged integrated porous orbital implants. Ophthal Plast Reconstr Surg. 2003;19:119-22.
37. Dolphin KW. Complications of postenucleation/evisceration implants. Curr Opin Ophthalmol 1998;9:75-7.
38. Purdy EP. Oculoplastic and orbital applications of porous high-density polyethylene implants. Curr Opin Ophthalmol 1997;8:57-63.
39. Karesh JW. Biomaterials in ophthalmic plastic and reconstructive surgery. Curr Opin Ophthalmol 1998;9:66-74.
40. Custer PL, Trinkaus KM, Fornoff J. Comparative motility of hydroxyapatite and alloplastic enucleation implants. Ophthalmology 1999;106:513-6.
41. Colen TP, Paridaens DA, Lemij HG, et al. Comparison of artificial eye amplitudes with acrylic and hydroxyapatite spherical enucleation implants. Ophthalmology 2000;107:1889-94.
42. Nunery WR, Heinz GW, Bonnin JM, et al. Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicone sphere implants. Ophthal Plast Reconstr Surg 1993;9:96-104.
43. Nunery WR, Cepela MA, Heinz GW, et al. Extrusion rate of silicone spherical anophthalmic socket implants. Ophthal Plast Reconstr Surg 1993;9:90-5.
44. Lang CJ, Heckmann JG, Neundorfer B. Creutzfeldt-Jakob disease via dural and corneal transplants. J Neurol Sci 1998;160:128-39.
45. Seiff SR, Chang JS Jr, Hurt MH, Khayam-Bashi H. Polymerase chain reaction identification of human immunodeficiency virus-1 in preserved human sclera. Am J Ophthalmol 1994;118:528-30.
46. Long JA, Tann TM III, Bearden WH III, Callahan MA. Enucleation: is wrapping the implant necessary for optimal motility? Ophthal Plast Reconstr Surg 2003;19:194-7.
47. Goldberg RA, Holds JB, Ebrahimpour J. Exposed hydroxyapatite orbital implants: report of six cases. Ophthalmology 1992;99:831-6.
48. Gayre GS, Lipham W, Dutton JJ. A comparison of rates of fibrovascular ingrowth in wrapped versus unwrapped hydroxyapatite spheres in a rabbit model. Ophthal Plast Reconstr Surg 2002;18:275-80.
49. Soparkar CN, Wong JF, Patrinely JR, et al. Porous polyethylene implant fibrovascularization rate is affected by tissue wrapping, agarose coating, and insertion site. Ophthal Plast Reconstr Surg 2000;16:330-6.
50. Suter AJ, Molteno AC, Bevin TH, et al. Long term follow up of bone derived hydroxyapatite orbital implants. Br J Ophthalmol 2002;86:1287-92.
51. Jordan DR, Klapper SR, Gilberg SM. The use of Vicryl mesh in 200 porous orbital implants: a technique with few exposures. Ophthal Plast Reconstr Surg 2003;19:53-61.
52. Edelstein C, Shields CL, De Potter P, Shields JA. Complications of motility peg placement for the hydroxyapatite orbital implant. Ophthalmology 1997;104:1616-21.
53. Jordan DR, Chan S, Mawn L, et al. Complications associated with pegging hydroxyapatite orbital implants. Ophthalmology 1999;106:505-12.
54. Lee SY, Jang JW, Lew H, et al. Complications in motility PEG placement for hydroxyapatite orbital implant in anophthalmic socket. Jpn J Ophthalmol 2002;46:103-7.
55. Lin CJ, Liao SL, Jou JR, et al. Complications of motility peg placement for porous hydroxyapatite orbital implants. Br J Ophthalmol 2002;86:394-6.
56. Abramson JH, Abramson ZH. Survey methods in community medicine: epidemiological research, programme evaluation, clinical trials. 5th ed. Edinburgh: Churchill Livingstone, 1999.
57. Custer PL, Kennedy RH, Woog JJ, et al. Orbital implants in enucleation surgery: a report by the American Academy of Ophthalmology. Ophthalmology 2003;110:2054-61.